$46 Million

IVERIC bio, Inc.

Follow-on Offering

Sole Bookrunner, December 2019

IVERIC bio, Inc.
IVERIC bio, Inc., formerly Ophthotech Corporation, is a biopharmaceutical company focused on the discovering and developing of novel treatment options for retinal diseases with significant unmet medical needs.